Naritaka Tanaka

1.4k total citations
58 papers, 1.1k citations indexed

About

Naritaka Tanaka is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Naritaka Tanaka has authored 58 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Surgery, 25 papers in Pulmonary and Respiratory Medicine and 16 papers in Molecular Biology. Recurrent topics in Naritaka Tanaka's work include Esophageal Cancer Research and Treatment (28 papers), Gastric Cancer Management and Outcomes (17 papers) and Esophageal and GI Pathology (12 papers). Naritaka Tanaka is often cited by papers focused on Esophageal Cancer Research and Treatment (28 papers), Gastric Cancer Management and Outcomes (17 papers) and Esophageal and GI Pathology (12 papers). Naritaka Tanaka collaborates with scholars based in Japan and Mongolia. Naritaka Tanaka's co-authors include Hiroyuki Kuwano, Makoto Sohda, Takanori Inose, Tatsuya Miyazaki, Masanobu Nakajima, Makoto Sakai, Akihiko Sano, Shigemasa Suzuki, Hiroyuki Kato and Takehiko Yokobori and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer and Annals of Surgery.

In The Last Decade

Naritaka Tanaka

53 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naritaka Tanaka Japan 21 467 437 362 273 251 58 1.1k
Anya N. Milne Netherlands 18 365 0.8× 478 1.1× 382 1.1× 473 1.7× 161 0.6× 32 1.1k
Julia Kitz Germany 22 426 0.9× 313 0.7× 280 0.8× 564 2.1× 296 1.2× 52 1.2k
Takeaki Fukuda Japan 16 343 0.7× 250 0.6× 292 0.8× 219 0.8× 217 0.9× 45 988
Yoichi Hamai Japan 21 376 0.8× 732 1.7× 646 1.8× 359 1.3× 151 0.6× 95 1.3k
Moubin Lin China 16 333 0.7× 288 0.7× 145 0.4× 413 1.5× 218 0.9× 54 978
Keisuke Matsusaki Japan 20 566 1.2× 245 0.6× 213 0.6× 385 1.4× 259 1.0× 43 1.1k
Akira Kabashima Japan 19 499 1.1× 415 0.9× 457 1.3× 530 1.9× 192 0.8× 53 1.2k
Tingyu Mou China 19 508 1.1× 360 0.8× 617 1.7× 513 1.9× 380 1.5× 48 1.5k
Sung‐Im Do South Korea 16 399 0.9× 145 0.3× 175 0.5× 340 1.2× 258 1.0× 84 913
Akira Ooki Japan 20 595 1.3× 331 0.8× 456 1.3× 617 2.3× 303 1.2× 98 1.4k

Countries citing papers authored by Naritaka Tanaka

Since Specialization
Citations

This map shows the geographic impact of Naritaka Tanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naritaka Tanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naritaka Tanaka more than expected).

Fields of papers citing papers by Naritaka Tanaka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naritaka Tanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naritaka Tanaka. The network helps show where Naritaka Tanaka may publish in the future.

Co-authorship network of co-authors of Naritaka Tanaka

This figure shows the co-authorship network connecting the top 25 collaborators of Naritaka Tanaka. A scholar is included among the top collaborators of Naritaka Tanaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naritaka Tanaka. Naritaka Tanaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
4.
Sohda, Makoto, Tatsuya Miyazaki, Makoto Sakai, et al.. (2019). Multidisciplinary Therapy for Locally Advanced Oesophageal Cancer With Special Reference to Surgical Conversion and Salvage. Anticancer Research. 39(6). 3167–3175. 4 indexed citations
5.
Sohda, Makoto, Hideyuki Saito, Kengo Kuriyama, et al.. (2019). Post-esophagectomy Adjuvant Chemotherapy Benefits Esophageal Cancer Patients. In Vivo. 33(2). 501–506. 15 indexed citations
6.
Sakai, Makoto, Makoto Sohda, Tatsuya Miyazaki, et al.. (2018). Association of Preoperative Nutritional Status with Prognosis in Patients with Esophageal Cancer Undergoing Salvage Esophagectomy. Anticancer Research. 38(2). 933–938. 20 indexed citations
7.
Muranushi, Ryo, Hideyuki Saito, Naritaka Tanaka, et al.. (2018). A case report of intracholecystic papillary neoplasm of the gallbladder resembling a submucosal tumor. SHILAP Revista de lepidopterología. 4(1). 124–124. 12 indexed citations
8.
Suzuki, Shigemasa, Takehiko Yokobori, Bolag Altan, et al.. (2017). High stathmin 1 expression is associated with poor prognosis and chemoradiation resistance in esophageal squamous cell carcinoma. International Journal of Oncology. 50(4). 1184–1190. 20 indexed citations
9.
Morinaga, Nobuhiro, Naritaka Tanaka, Yoshinori Shitara, et al.. (2016). Ten-Year Survival of a Patient Treated with Stereotactic Gamma Knife Radiosurgery for Brain Metastases from Colon Cancer with Ovarian and Lymph Node Metastases: A Case Report. Case Reports in Gastroenterology. 10(1). 204–211. 3 indexed citations
10.
Miyazaki, Tatsuya, Makoto Sohda, Naritaka Tanaka, et al.. (2014). Phase I/II study of docetaxel, cisplatin, and 5-fluorouracil combination chemoradiotherapy in patients with advanced esophageal cancer. Cancer Chemotherapy and Pharmacology. 75(3). 449–455. 29 indexed citations
11.
12.
Yokobori, Takehiko, Shigemasa Suzuki, Naritaka Tanaka, et al.. (2012). MiR‐150 is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducer ZEB1. Cancer Science. 104(1). 48–54. 111 indexed citations
13.
Inose, Takanori, Tatsuya Miyazaki, Shigemasa Suzuki, et al.. (2012). Surgical treatment for nonspecific esophageal motility disorders. Surgery Today. 43(8). 877–882.
14.
Miyazaki, Tatsuya, Naritaka Tanaka, Takehiko Yokobori, et al.. (2011). Ghrelin Level and Body Weight Loss After Esophagectomy for Esophageal Cancer. Journal of Surgical Research. 176(1). 74–78. 20 indexed citations
15.
Sakai, Makoto, Makoto Sohda, Tatsuya Miyazaki, et al.. (2010). Significance of karyopherin-{alpha} 2 (KPNA2) expression in esophageal squamous cell carcinoma.. PubMed. 30(3). 851–6. 68 indexed citations
16.
Tanaka, Naritaka, Hitoshi Kimura, Ahmad Faried, et al.. (2010). Quantitative analysis of cisplatin sensitivity of human esophageal squamous cancer cell lines using in‐air micro‐PIXE. Cancer Science. 101(6). 1487–1492. 13 indexed citations
17.
Sakai, Makoto, Hiroyuki Kato, Akihiko Sano, et al.. (2009). Expression of Lysyl Oxidase Is Correlated with Lymph Node Metastasis and Poor Prognosis in Esophageal Squamous Cell Carcinoma. Annals of Surgical Oncology. 16(9). 2494–2501. 36 indexed citations
18.
Kato, Hiroyuki, Masanobu Nakajima, Makoto Sohda, et al.. (2009). The clinical application of 18F‐fluorodeoxyglucose positron emission tomography to predict survival in patients with operable esophageal cancer. Cancer. 115(14). 3196–3203. 67 indexed citations
19.
Sano, Akihiko, Hiroyuki Kato, Shinji Sakurai, et al.. (2008). CD24 Expression Is a Novel Prognostic Factor in Esophageal Squamous Cell Carcinoma. Annals of Surgical Oncology. 16(2). 506–514. 67 indexed citations
20.
Kato, Hiroyuki, Minoru Fukuchi, Tatsuya Miyazaki, et al.. (2007). Surgical Treatment for Esophageal Cancer. Digestive Surgery. 24(2). 88–95. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026